Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Broad Great Industry Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs and traditional Chinese medicines (TCM). The company operates large-scale production facilities that produce a variety of dosage forms, including tablets, capsules, and injections, with a focus on cardiovascular, respiratory, and anti-infective therapeutic areas. It is recognized for its integration of modern pharmaceutical technology with traditional herbal formulations to serve the domestic Chinese market. The firm maintains Good Manufacturing Practice (GMP) certified facilities and emphasizes quality control across its diverse product portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Broad Great Industry Pharmaceutical.